VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Patent Process Glitch

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Mar 31, 2022 6:04pm

177 Views

Post# 34564851

RE:RE:RE:Patent Process Glitch

Another small step forward today:

Transaction History

Date	Transaction Description
03-31-2022	Information Disclosure Statement considered
03-29-2022	Date Forwarded to Examiner

Pandora wrote:
Seems the patent application for the new probe is back on track again:

Transaction History
Email Notification

Date Transaction Description

03-29-2022 Date Forwarded to Examiner

03-23-2022 Response after Non-Final Action

03-21-2022

16/757,755 DEVICE, SYSTEM AND/OR METHOD FOR POSITION TRACKING 0822-053796